{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:55Z","timestamp":1793387215246,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00976-6","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T18:43:35Z","timestamp":1747334615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Biliary microbiome profiling via 16 S rRNA amplicon sequencing in patients with cholangiocarcinoma, pancreatic carcinoma and choledocholithiasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroki","family":"Mizutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Oosuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuichi","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Nishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Moritani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kaiju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"1","key":"976_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41575-019-0242-7","volume":"17","author":"RM Thomas","year":"2020","unstructured":"Thomas, R. M. & Jobin, C. Microbiota in pancreatic health and disease: the next frontier in Microbiome research. Nat. Rev. Gastroenterol. Hepatol. Jan. 17 (1), 53\u201364 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol. Jan"},{"issue":"10","key":"976_CR2","first-page":"2598","volume":"20","author":"C Ye","year":"2023","unstructured":"Ye, C., Dong, C., Lin, Y., Shi, H. & Zhou, W. Interplay between the human Microbiome and biliary tract Cancer. Implications Pathogenesis Therapy Microorganisms Oct. 20 (10), 2598 (2023).","journal-title":"Implications Pathogenesis Therapy Microorganisms Oct."},{"issue":"8","key":"976_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gutjnl-2019-319807","volume":"27","author":"V Chandra","year":"2021","unstructured":"Chandra, V. & McAllister, F. Therapeutic potential of microbial modulation in pancreatic cancer. Gut Apr. 27 (8), 1419\u20131425 (2021).","journal-title":"Gut Apr"},{"issue":"1","key":"976_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","volume":"Jul;163","author":"N Nagata","year":"2022","unstructured":"Nagata, N. et al. Metagenomic identification of microbial signatures predicting pancreatic Cancer from a multinational study. Gastroenterology Jul;163 (1), 222\u2013238 (2022).","journal-title":"Gastroenterology"},{"key":"976_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2147\/IDR.S200378","volume":"11;12","author":"P Di Carlo","year":"2019","unstructured":"Di Carlo, P. et al. The microbiota of the bilio-pancreatic system: a cohort, STROBE-compliant study. Infect. Drug Resist. Jun. 11;12, 1513\u20131527 (2019).","journal-title":"Infect. Drug Resist. Jun"},{"issue":"1","key":"976_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","volume":"20","author":"MY Wei","year":"2019","unstructured":"Wei, M. Y. et al. The microbiota and Microbiome in pancreatic cancer: more influential than expected. Mol. Cancer May. 20 (1), 97 (2019).","journal-title":"Mol. Cancer May"},{"key":"976_CR7","doi-asserted-by":"crossref","unstructured":"Stasiewicz, M., Kwa\u015bniewski, M. & Karpi\u0144ski, T. M. Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers. Cancers (Basel). Jul 27;13(15):3784 (2021).","DOI":"10.3390\/cancers13153784"},{"issue":"3","key":"976_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.30852","volume":"71","author":"X Jia","year":"2020","unstructured":"Jia, X. et al. Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma. Hepatol. Mar. 71 (3), 893\u2013906 (2020).","journal-title":"Hepatol. Mar."},{"key":"976_CR9","doi-asserted-by":"crossref","unstructured":"Papa, V. et al. The Role of Microbiota in Pancreatic Cancer. Cancers (Basel). Jun 11;15(12):3143 (2023).","DOI":"10.3390\/cancers15123143"},{"issue":"1","key":"976_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/ars.2008.2109","volume":"11","author":"PS Leung","year":"2009","unstructured":"Leung, P. S. & Chan, Y. C. Role of oxidative stress in pancreatic inflammation. Antioxid. Redox Signal. Jan. 11 (1), 135\u2013165 (2009).","journal-title":"Antioxid. Redox Signal. Jan"},{"issue":"4","key":"976_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tcb.2021.01.007","volume":"31","author":"Y Ma","year":"2021","unstructured":"Ma, Y. & Hao, J. Dedifferentiation of epithelial cells incorporates immune reprogramming. Trends Cell. Biol. Apr. 31 (4), 237\u2013240 (2021).","journal-title":"Trends Cell. Biol. Apr"},{"issue":"5","key":"976_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4251\/wjgo.v15.i5.713","volume":"May 15","author":"SW Guan","year":"2023","unstructured":"Guan, S. W., Lin, Q. & Yu, H. B. Intratumour Microbiome of pancreatic cancer. World J. Gastrointest. Oncol. May 15 (5), 713\u2013730 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"976_CR13","doi-asserted-by":"publisher","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","volume":"15","author":"X Chai","year":"2023","unstructured":"Chai, X. et al. Intratumor Microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microbes Jan-Dec. 15 (1), 2156255 (2023).","journal-title":"Gut Microbes Jan-Dec"},{"issue":"5","key":"976_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00535-024-02090-2","volume":"59","author":"HY Xin","year":"2024","unstructured":"Xin, H. Y. et al. Characterization of tumor Microbiome and associations with prognosis in intrahepatic cholangiocarcinoma. J. Gastroenterol. May. 59 (5), 411\u2013423 (2024).","journal-title":"J. Gastroenterol. May"},{"issue":"6356","key":"976_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"Sep15;357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science Sep15;357 (6356), 1156\u20131160 (2017).","journal-title":"Science"},{"issue":"1","key":"976_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/gutjnl-2022-328834","volume":"73","author":"SC Thomas","year":"2024","unstructured":"Thomas, S. C., Miller, G., Li, X. & Saxena, D. Getting off tract: contributions of intraorgan microbiota to cancer in extraintestinal organs. Gut 73 (1), 175\u2013185 (2024).","journal-title":"Gut"},{"issue":"1","key":"976_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-023-01334-6","volume":"Feb 1","author":"Z Zong","year":"2023","unstructured":"Zong, Z., Zhou, F. & Zhang, L. The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal. Transduct. Target. Ther. Feb 1 (1), 50 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"20","key":"976_CR18","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"29","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza, L. et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. Sep. 29 (20), 3789\u20133806e17 (2022).","journal-title":"Cell. Sep."},{"issue":"7777","key":"976_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut, B. et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nat. Oct. 574 (7777), 264\u2013267 (2019).","journal-title":"Nat. Oct."},{"issue":"4","key":"976_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.synbio.2021.11.002","volume":"24","author":"Z Lyu","year":"2021","unstructured":"Lyu, Z. et al. Analysis of the relationship between bile duct and duodenal microbiota reveals that potential dysbacteriosis is the main cause of primary common bile duct stones. Synth. Syst. Biotechnol. Nov. 24 (4), 414\u2013428 (2021).","journal-title":"Synth. Syst. Biotechnol. Nov"},{"key":"976_CR21","doi-asserted-by":"publisher","first-page":"625589","DOI":"10.3389\/fcimb.2021.625589","volume":"29;11","author":"J Han","year":"2021","unstructured":"Han, J., Wu, S., Fan, Y., Tian, Y. & Kong, J. Biliary microbiota in choledocholithiasis and correlation with duodenal microbiota. Front. Cell. Infect. Microbiol. Apr. 29;11, 625589 (2021).","journal-title":"Front. Cell. Infect. Microbiol. Apr"},{"issue":"2","key":"976_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","volume":"28","author":"E Del Castillo","year":"2019","unstructured":"Del Castillo, E. et al. The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic Cancer and noncancer subjects. Cancer Epidemiol. Biomarkers Prev. Feb. 28 (2), 370\u2013383 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev. Feb"},{"issue":"2","key":"976_CR23","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/j.cgh.2020.11.006","volume":"20","author":"S Kohi","year":"2022","unstructured":"Kohi, S. et al. Alterations in the duodenal fluid Microbiome of patients with pancreatic Cancer. Clin. Gastroenterol. Hepatol. Feb. 20 (2), e196\u2013e227 (2022).","journal-title":"Clin. Gastroenterol. Hepatol. Feb"},{"issue":"4","key":"976_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar, S. et al. The pancreatic Cancer Microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov Apr. 8 (4), 403\u2013416 (2018).","journal-title":"Cancer Discov Apr"},{"issue":"4","key":"976_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000095424","volume":"73","author":"T Kamisawa","year":"2006","unstructured":"Kamisawa, T. & Okamoto, A. Biliopancreatic and pancreatobiliary refluxes in cases with and without pancreaticobiliary maljunction: diagnosis and clinical implications. Digestion 73 (4), 228\u2013236 (2006).","journal-title":"Digestion"},{"issue":"1","key":"976_CR26","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1038\/s41598-024-59737-6","volume":"18","author":"M Xiao","year":"2024","unstructured":"Xiao, M. et al. The dysregulation of biliary tract microflora is closely related to primary choledocholithiasis: a multicenter study. Sci. Rep. Apr. 18 (1), 9004 (2024).","journal-title":"Sci. Rep. Apr"},{"issue":"2","key":"976_CR27","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1002\/ctm2.97","volume":"10","author":"X Song","year":"2020","unstructured":"Song, X. A metagenomic study of biliary Microbiome change along the cholecystitis-carcinoma sequence. Clin. Transl Med. Jun. 10 (2), e97 (2020).","journal-title":"Clin. Transl Med. Jun"},{"issue":"1","key":"976_CR28","doi-asserted-by":"publisher","first-page":"8766","DOI":"10.1038\/s41598-022-12658-8","volume":"24","author":"S Okuda","year":"2022","unstructured":"Okuda, S. et al. Unveiling Microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer. Sci. Rep. May. 24 (1), 8766 (2022).","journal-title":"Sci. Rep. May"},{"issue":"3","key":"976_CR29","doi-asserted-by":"publisher","first-page":"e0247798","DOI":"10.1371\/journal.pone.0247798","volume":"Mar 9","author":"M Saab","year":"2021","unstructured":"Saab, M. et al. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma. PLoS One. Mar 9 (3), e0247798 (2021).","journal-title":"PLoS One"},{"key":"976_CR30","first-page":"1092563","volume":"25;2019","author":"B Chen","year":"2019","unstructured":"Chen, B., Fu, S. W., Lu, L. & Zhao, H. A preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma. Biomed. Res. Int. Sep. 25;2019, 1092563 (2019).","journal-title":"Biomed. Res. Int. Sep."},{"key":"976_CR31","doi-asserted-by":"crossref","unstructured":"Ito, Z. et al. Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer. Cancers (Basel). Oct 31;14(21):5379 (2022).","DOI":"10.3390\/cancers14215379"},{"issue":"5","key":"976_CR32","first-page":"2962","volume":"15","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Characteristics of bile microbiota in cholelithiasis, Perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer. Am. J. Transl Res. May. 15 (5), 2962\u20132971 (2022).","journal-title":"Am. J. Transl Res. May"},{"key":"976_CR33","doi-asserted-by":"crossref","unstructured":"Dangtakot, R. et al. Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients. Asian Pac J Cancer Prev. Jan 1;22(1):233\u2013240 (2021).","DOI":"10.31557\/APJCP.2021.22.1.233"},{"issue":"4","key":"976_CR34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bbrc.2018.10.169","volume":"2","author":"T Maekawa","year":"2018","unstructured":"Maekawa, T. et al. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochem. Biophys. Res. Commun. Dec. 2 (4), 962\u2013969 (2018).","journal-title":"Biochem. Biophys. Res. Commun. Dec."},{"key":"976_CR35","doi-asserted-by":"crossref","unstructured":"Avil\u00e9s-Jim\u00e9nez, F. et al. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma. Clin Microbiol Infect. Feb;22(2):178.e11-178.e22 (2016).","DOI":"10.1016\/j.cmi.2015.10.008"},{"issue":"2","key":"976_CR36","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1002\/ctm2.97","volume":"10","author":"X Song","year":"2020","unstructured":"Song, X. et al. A metagenomics study of biliary Microbiome change along the cholecystitis-carcinoma sequence. Clin. Transl Med. Jun. 10 (2), e97 (2020).","journal-title":"Clin. Transl Med. Jun"},{"issue":"9","key":"976_CR37","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/cancers12092672","volume":"12","author":"J Chakladar","year":"2020","unstructured":"Chakladar, J. et al. The pancreatic Microbiome is associated with carcinogenesis and worse prognosis in males and smokers. Cancers (Basel). 12 (9), 2672 (2020). Sep 18.","journal-title":"Cancers (Basel)"},{"issue":"6494","key":"976_CR38","first-page":"973","volume":"29","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor Microbiome is composed of tumor type-specific intracellular bacteria. Sci. May. 29 (6494), 973\u2013980 (2020).","journal-title":"Sci. May"},{"issue":"6","key":"976_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/07357907.2024.2361305","volume":"42","author":"R Shukla","year":"2024","unstructured":"Shukla, R. et al. Metagenomic analysis of biliary microbial flora in patients with gallbladder Cancer or Gallstones-Associated chronic cholecystitis. Cancer Invest. Jul. 42 (6), 478\u2013490 (2024).","journal-title":"Cancer Invest. Jul"},{"issue":"2","key":"976_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/gutjnl-2018-317200","volume":"68","author":"Z He","year":"2019","unstructured":"He, Z. et al. <i\u2009>\u2009Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin<\/i\u2009>. Gut Feb. 68 (2), 289\u2013300 (2019).","journal-title":"Gut Feb"},{"key":"976_CR41","doi-asserted-by":"publisher","first-page":"790256","DOI":"10.3389\/fmicb.2021.790256","volume":"8","author":"JW Duijster","year":"2021","unstructured":"Duijster, J. W., Franz, E., Neefjes, J. & Mughini-Gras, L. Bacterial and parasitic pathogens as risk factors for cancers in the Gastrointestinal tract: A review of current epidemiological knowledge. Front. Microbiol. Dec. 8, 12:790256 (2021).","journal-title":"Front. Microbiol. Dec."},{"issue":"5","key":"976_CR42","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1499-3872(16)60109-1","volume":"15","author":"IH Kim","year":"2016","unstructured":"Kim, I. H. et al. Clinical significance of isolated biliary candidiasis in patients with unresectable cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int. Oct. 15 (5), 533\u2013539 (2016).","journal-title":"Hepatobiliary Pancreat. Dis. Int. Oct."},{"issue":"10","key":"976_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/microorganisms7100459","volume":"16","author":"F Nogueira","year":"2019","unstructured":"Nogueira, F., Sharghi, S., Kuchler, K. & Lion, T. Pathogenetic impact of Bacterial- fungal interactions. Microorganisms Oct. 16 (10), 459 (2019).","journal-title":"Microorganisms Oct."},{"issue":"1","key":"976_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-021-00256-7","volume":"30","author":"VA Kiesel","year":"2021","unstructured":"Kiesel, V. A. et al. Pyruvate carboxylase and cancer progression. Cancer Metab. Apr. 30 (1), 20 (2021).","journal-title":"Cancer Metab. Apr"},{"key":"976_CR45","doi-asserted-by":"publisher","first-page":"1331641","DOI":"10.3389\/fimmu.2024.1331641","volume":"29","author":"D Li","year":"2024","unstructured":"Li, D. et al. The roles of Epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy. Front. Immunol. Jan. 29, 15:1331641 (2024).","journal-title":"Front. Immunol. Jan"},{"key":"976_CR46","doi-asserted-by":"crossref","unstructured":"Keeley, T. S., Yang, S. & Lau, E. The Diverse Contributions of Fucose Linkages in Cancer. Cancers (Basel). Aug 24;11(9):1241 (2019).","DOI":"10.3390\/cancers11091241"},{"issue":"2","key":"976_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/1568011033353470","volume":"3","author":"X Chen","year":"2003","unstructured":"Chen, X., Wu, B. & Wang, P. G. Glucuronides in anti-cancer therapy. Curr. Med. Chem. Anticancer Agents Mar. 3 (2), 139\u2013150 (2003).","journal-title":"Curr. Med. Chem. Anticancer Agents Mar."},{"key":"976_CR48","doi-asserted-by":"crossref","unstructured":"Tucker, O. N., Dannenberg, A. J., Yang, E. K. & Fahey, T. J. 3 Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinog. Mar. 25 (3), 419\u2013423 (2004).","DOI":"10.1093\/carcin\/bgh010"},{"key":"976_CR49","doi-asserted-by":"crossref","unstructured":"Malhotra, P., Palanisamy, R., Caparros-Martin, J. A. & Falasca, M. Bile Acids and Microbiota Interplay in Pancreatic Cancer. Cancers (Basel). Jul 11;15(14):3573 (2023).","DOI":"10.3390\/cancers15143573"},{"issue":"1","key":"976_CR50","doi-asserted-by":"publisher","first-page":"22088","DOI":"10.1038\/s41598-020-79181-6","volume":"16","author":"E G\u00e1l","year":"2020","unstructured":"G\u00e1l, E. et al. Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. Sci. Rep. Dec. 16 (1), 22088 (2020).","journal-title":"Sci. Rep. Dec."},{"key":"976_CR51","doi-asserted-by":"publisher","first-page":"105775","DOI":"10.1016\/j.jsbmb.2020.105775","volume":"205","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls. J. Steroid Biochem. Mol. Biol. Jan. 205, 105775 (2021).","journal-title":"J. Steroid Biochem. Mol. Biol. Jan"},{"issue":"1","key":"976_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41598-023-50957-w","volume":"4","author":"EN Wallace","year":"2024","unstructured":"Wallace, E. N. et al. An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry. Sci. Rep. Jan. 4 (1), 489 (2024).","journal-title":"Sci. Rep. Jan"},{"key":"976_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/bs.acr.2014.11.001","volume":"126","author":"N Taniguchi","year":"2015","unstructured":"Taniguchi, N. & Kizuka, Y. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv. Cancer Res. 126, 11\u201351 (2015).","journal-title":"Adv. Cancer Res."},{"key":"976_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"976_CR55","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00976-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00976-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T20:03:16Z","timestamp":1747339396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00976-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00976-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16966"}}